Ailiang Zeng

2.8k total citations · 1 hit paper
42 papers, 2.0k citations indexed

About

Ailiang Zeng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ailiang Zeng has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Ailiang Zeng's work include MicroRNA in disease regulation (20 papers), Circular RNAs in diseases (18 papers) and Cancer-related molecular mechanisms research (15 papers). Ailiang Zeng is often cited by papers focused on MicroRNA in disease regulation (20 papers), Circular RNAs in diseases (18 papers) and Cancer-related molecular mechanisms research (15 papers). Ailiang Zeng collaborates with scholars based in China, United States and Türkiye. Ailiang Zeng's co-authors include Yongping You, Jianxing Yin, Zhuoran Zhang, Wei Yan, Chenfei Lu, Yutian Wei, Xiaoxu Huang, Zhumei Shi, Xu Zhou and Qi Hu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Ailiang Zeng

40 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression

2019 323 citations Xiaoxu Huang, Zheng Li et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Ailiang Zeng

Since Specialization

Citations

This map shows the geographic impact of Ailiang Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailiang Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailiang Zeng more than expected).

Fields of papers citing papers by Ailiang Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailiang Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailiang Zeng. The network helps show where Ailiang Zeng may publish in the future.

Co-authorship network of co-authors of Ailiang Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Ailiang Zeng. A scholar is included among the top collaborators of Ailiang Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailiang Zeng. Ailiang Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Hsa_circ_0002301 inhibits ferroptosis in gastric cancer by encoding the de novo protein HECTD1-463aa	Journal of Translational Medicine	Song Wang, Chengwei Wu et al.	2
2	LBA18 Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for patients (pts) with HER2+ advanced/metastatic breast cancer (a/mBC): Additional analyses of DESTINY-Breast09 in key subgroups of interest	Annals of Oncology	Romualdo Barroso‐Sousa, Y.H. Park et al.	0
3	MiRNA-loaded MSC exosomes restore autophagy flux for acute pancreatitis therapy	Frontiers in Immunology	Haojie Zeng, Si Luo et al.	0
4	METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling	Cell Death and Disease	Jianxing Yin, Xin Ge et al.	37
5	Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly	Journal of neurosurgery	Shaolin Zhang, Shun Yao et al.	5
6	7MO Oritinib (SH-1028) a third-generation EGFR tyrosine kinase inhibitor in locally advanced or metastatic NSCLC patients with positive EGFR T790M: Results of a single-arm phase II trial	Annals of Oncology	C.Z. Zhou, Yimin Mao et al.	2
7	Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond	Frontiers in Oncology	Najat Bouchmaa, Bouchra Taïb et al.	41
8	Qki activates Srebp2-mediated cholesterol biosynthesis for maintenance of eye lens transparency	Nature Communications	Seula Shin, Hao Zhou et al.	30
9	CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis	Biochemical and Biophysical Research Communications	Qiang Zhang, Hao Hu et al.	44
10	Establishing a novel prediction model for improving the positive rate of prostate biopsy	Translational Andrology and Urology	Tao Tao, Ailiang Zeng et al.	6
11	Hormone levels are related to functional compensation in prolactinomas: A resting-state fMRI study	Journal of the Neurological Sciences	Shun Yao, Pan Lin et al.	8
12	Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism	iScience	Ailiang Zeng, Zhiyun Wei et al.	47
13	MicroRNA-3662 targets ZEB1 and attenuates the invasion of the highly aggressive melanoma cell line A375	SHILAP Revista de lepidopterología	Liu Z, Rui Dong et al.	2
14	Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma	EBioMedicine	Jianxing Yin, Ailiang Zeng et al.	152
15	Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression breakdown →	Molecular Cancer	Xiaoxu Huang, Zheng Li et al.	323
16	S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF‐κB positive feedback loop	Journal of Cellular and Molecular Medicine	Yiming Tu, Peng Xie et al.	39
17	Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma	Cancer Letters	Ailiang Zeng, Zhiyun Wei et al.	161
18	Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma	Oncogene	Er Nie, Xin Jin et al.	37
19	Tumour exosomes from cells harbouring PTPRZ1–MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma	Oncogene	Ailiang Zeng, Wei Yan et al.	100
20	Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway	Cellular Physiology and Biochemistry	Xin Jin, Er Nie et al.	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact